CD8A and ovarian cancer: The authors investigated predictive markers for ICIs in ovarian cancer patients and suggested the presence of activated classical monocytes, naïve and/or central memory CD4+ T cells, as well as a higher density of CD8+ T cells and CD20+ B cells and the presence of tertiary lymphoid structures in tumors, associated with durable responses.